Log In
BCIQ
Print this Print this
 

FIM-5240

  Manage Alerts
Collapse Summary General Information
Company Fimbrion Therapeutics Inc.
Description 
Molecular Target
Mechanism of ActionBacterial adhesion antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationUrinary tract infection (UTI)
Indication DetailsTreat urinary tract infection (UTI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today